WebFeb 22, 2024 · Statera Biopharma, Inc. (formerly Cytocom, Inc.) is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and ... Web--Cytocom, Inc., a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced plans to …
Cytocom, Inc. Announces Plan to Adopt New Corporate Name …
WebOct 27, 2024 · Statera Biopharma (formerly Cytocom, Inc.) is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers... WebUntil the transaction is completed, Cytocom (now, Statera Biopharma, Inc.) does not have a clear title and interest to our Company’s technology. In March 2024, the Company and Cytocom negotiated an amendment to the licensing agreement (“Third License Amendment”) which has been submitted to the board of directors of Cytocom for approval. standard pms contract
Cytocom, Inc. Announces Plan to Adopt New Corporate Name …
WebApr 10, 2024 · Subsequent to the merger, CBLI adopted a new corporate name, "Statera BioPharma, Inc.", with the ticker symbol "STAB," effective on September 1, 2024 ("Statera"). Statera emerged as a publicly ... WebAug 29, 2024 · 29 Aug 2024 by Datacenters.com Colocation. Ashburn, a city in Virginia’s Loudoun County about 34 miles from Washington D.C., is widely known as the Data … WebApr 13, 2024 · Statera Biopharma (formerly Cytocom, Inc.) is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers based on a proprietary platform designed to rebalance the body’s immune system and restore homeostasis. Statera has … standard pneumatic action company